AU2003207628A8 - Structural and cytoskeleton-associated proteins - Google Patents

Structural and cytoskeleton-associated proteins

Info

Publication number
AU2003207628A8
AU2003207628A8 AU2003207628A AU2003207628A AU2003207628A8 AU 2003207628 A8 AU2003207628 A8 AU 2003207628A8 AU 2003207628 A AU2003207628 A AU 2003207628A AU 2003207628 A AU2003207628 A AU 2003207628A AU 2003207628 A8 AU2003207628 A8 AU 2003207628A8
Authority
AU
Australia
Prior art keywords
cytoskeleton
structural
associated proteins
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2003207628A
Other versions
AU2003207628A1 (en
Inventor
Yuming Xu
April J A Hafalia
Soo Yeun Lee
Jennifer A Griffin
Sally Lee
Ian J Forsythe
Patricia M Lehr-Mason
Ann E Gorvad
Thomas W Richardson
Y Tom Tang
Jayalaxmi Ramkumar
Sean A Bulloch
Joseph P Marquis
Chandra S Arvizu
Kavitha Thangavelu
Alan A Jackson
Anita Swarnakar
Dyung Aina M Lu
Reena Khare
Henry Yue
Mariah R Baughn
Xin Jiang
Shanya D Becha
Vicki S Elliott
Narinder K Chawla
Amy E Kable
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp filed Critical Incyte Corp
Publication of AU2003207628A1 publication Critical patent/AU2003207628A1/en
Publication of AU2003207628A8 publication Critical patent/AU2003207628A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU2003207628A 2002-01-18 2003-01-16 Structural and cytoskeleton-associated proteins Abandoned AU2003207628A1 (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US35070202P 2002-01-18 2002-01-18
US60/350,702 2002-01-18
US35171502P 2002-01-25 2002-01-25
US60/351,715 2002-01-25
US35740202P 2002-02-15 2002-02-15
US60/357,402 2002-02-15
US37988002P 2002-05-10 2002-05-10
US60/379,880 2002-05-10
US38159902P 2002-05-17 2002-05-17
US60/381,599 2002-05-17
US38727002P 2002-06-07 2002-06-07
US60/387,270 2002-06-07
US39712502P 2002-07-19 2002-07-19
US60/397,125 2002-07-19
PCT/US2003/001772 WO2003062391A2 (en) 2002-01-18 2003-01-16 Structural and cytoskeleton-associated proteins

Publications (2)

Publication Number Publication Date
AU2003207628A1 AU2003207628A1 (en) 2003-09-02
AU2003207628A8 true AU2003207628A8 (en) 2006-11-09

Family

ID=27617990

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003207628A Abandoned AU2003207628A1 (en) 2002-01-18 2003-01-16 Structural and cytoskeleton-associated proteins

Country Status (2)

Country Link
AU (1) AU2003207628A1 (en)
WO (1) WO2003062391A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1896588B1 (en) * 2005-06-17 2009-08-12 National Research Council Of Canada NOVEL Aß-BINDING PROTEIN AND ITS PEPTIDE DERIVATIVES AND USES THEREOF
WO2007041439A2 (en) * 2005-09-30 2007-04-12 New England Medical Center Hospitals, Inc. Centrosomal proteins, nucleic acids and method of use thereof
KR20130110170A (en) 2010-09-22 2013-10-08 앨리오스 바이오파마 인크. Substituted nucleotide analogs
WO2013096680A1 (en) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
CN104321333A (en) 2012-03-21 2015-01-28 沃泰克斯药物股份有限公司 Solid forms of a thiophosphoramidate nucleotide prodrug
EP2827876A4 (en) 2012-03-22 2015-10-28 Alios Biopharma Inc Pharmaceutical combinations comprising a thionucleotide analog
TW202304970A (en) 2016-08-26 2023-02-01 德商英麥提克生物技術股份有限公司 Novel peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
US20220396841A1 (en) * 2019-12-02 2022-12-15 Viome Life Sciences, Inc. Detection and elimination of aberrant cells

Also Published As

Publication number Publication date
WO2003062391A2 (en) 2003-07-31
AU2003207628A1 (en) 2003-09-02
WO2003062391A3 (en) 2006-08-17

Similar Documents

Publication Publication Date Title
IL225633A0 (en) Anti-alpha-v-beta - 6 antibodies and uses thereof
EP1539941A4 (en) Adzymes and uses thereof
EP1551447A4 (en) Anti-addl antibodies and uses thereof
PT2702871T (en) Collagen biofabric and use thereof
AU2003296369A8 (en) Imminoamines and preparation thereof
IL165112A0 (en) Variant integrinpolypeptides and thereof
AU2003207628A8 (en) Structural and cytoskeleton-associated proteins
IL166063A0 (en) Antibodies and uses thereof
AU2003226899A8 (en) Human diabetes-mediating proteins
AU2003272423A8 (en) Centrosome proteins and uses thereof
AU2002312373A1 (en) Structural and cytoskeleton-associated proteins
AU2003231827A8 (en) Pseudo-tissues and uses thereof
AU2003302173A8 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
GB0317376D0 (en) Immunogenic protein and uses thereof
EP1541677A4 (en) Novel proteins and use thereof
EP1577322A4 (en) Novel proteins and use thereof
AU2003276933A8 (en) Structural and cytoskeleton-associated proteins
AU2003300859A8 (en) Carrier-ligand fusions and uses thereof
AU2002320621A1 (en) Structural and cytoskeleton-associated proteins
AU2002343516A1 (en) Structural and cytoskeleton-associated proteins
AU2003216442A8 (en) Enkurin and uses thereof
AU2003228397A8 (en) Hausp-p53 interaction and uses thereof
GB0223860D0 (en) Polypeptide methods and means
AU2003263751A8 (en) Novel proteins and their uses
AU2003265814A8 (en) Aw755252-interacting proteins and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase